Story perspectives

Researchers Optimize Lipid Nanoparticles for mRNA Vaccine Delivery

11/8/2025

Summary

Story summary

Lipid nanoparticles (LNPs) are being optimized to deliver mRNA vaccines, with cationic lipids used to enhance intracellular delivery.
Researchers are designing biodegradable lipids to enable effective RNA interference (RNAi) therapeutics.
Lipid formulations are advancing the immunogenicity of mRNA vaccines.
Safety and biodistribution have been evaluated in both human and animal studies to inform responses to infectious diseases such as SARS-CoV-2 and influenza.

1 of 1

Story summary

Lipid nanoparticles (LNPs) are being optimized to deliver mRNA vaccines, with cationic lipids used to enhance intracellular delivery.
Researchers are designing biodegradable lipids to enable effective RNA interference (RNAi) therapeutics.
Lipid formulations are advancing the immunogenicity of mRNA vaccines.
Safety and biodistribution have been evaluated in both human and animal studies to inform responses to infectious diseases such as SARS-CoV-2 and influenza.